capitalbiotech产品代理

产品分类 > 科研试剂 > capitalbiotech产品代理

capitalbiotech产品代理

CapitalBio Technology 是一家行业领先的生命科学公司,致力于开发和商业化整体医疗保健解决方案。我们公司为从生物医学研究人员到医疗保健专业人员的多元化客户群提供全面的优质产品组合。我们的产品包括用于基础和转化研究、药物开发、临床诊断、生物安全和食品安全以及分子育种的创新和广泛的微阵列和微流控芯片及相关仪器、软件和数据库、试剂和耗材。
作为首都生物科技股份有限公司和生物芯片北京国家工程技术研究中心的核心子公司,首都生物科技于2012年8月注册成立,总部位于北京经济技术开发区。 CapitalBio Technology 是一家领先的生命科学公司,致力于开发和商业化整体医疗保健解决方案。 CapitalBio Technology拥有超过35,000平方米的办公空间,拥有500多名员工;这些员工中 86% 至少拥有学士学位,其中 14 名是博士或博士后。
我们努力应对我们面临的挑战,让我们的公司以协作互动、高效解决问题和始终如一的客户满意度为中心。随着技术的快速进步显而易见且迫在眉睫,我们认识到提供不仅具有原创性和创造性,而且具有灵活性和可扩展性并由行业领先的支持和服务支持的解决方案至关重要。作为其领域和行业的先驱,CapitalBio Technology 能够为基因组学、蛋白质组学和代谢组学的研究界提供这些服务。
价格: 0.00

CapitalBio Technology is an industry-leading life science company   that develops and commercializes total health-care solutions. Our company   provides a comprehensive portfolio of top-quality products to a diverse   customer base ranging from biomedical researchers to healthcare   professionals. Our products include an innovative and broad spectrum of   microarray and microfluidic chips and related instruments, software and   databases, reagents and consumables for basic and translational research,   drug development, clinical diagnostics, biosafety and food safety, and   molecular breeding.

   

As a core subsidiary of CapitalBio Corporation and the Biological Chip Beijing National Engineering Research Center, CapitalBio Technology was registered in August 2012 and is

headquartered in Economic-Technological Development Area in   Beijing. CapitalBio Technology is a leading life science company that   develops and commercializes total health-care solutions. With more than   35,000 square meters of office space, CapitalBio Technology employs more than   500 employees; 86 percent of these employees have at least Bachelor-level   degrees, 14 of which are doctors or post-doctorates.

   

We strive to meet the challenges we face by centering our company around collaborative interaction, efficient problem-solving, and consistent customer satisfaction. With rapid advances in technology apparent and imminent, we recognize that it is crucial to offer solutions that are not only original and inventive, but also flexible and scalable and backed by industry-leading support and services. As a pioneer in its field and industry, CapitalBio Technology is able to provide these services for the research community in genomics, proteomics and metabolomics.